PDCI Market Access | News

October 6, 2022 / News, PMPRB, What's New

The Patented Medicine Prices Review Board (PMPRB) today, Ocober 6, 2022, released its draft PMPRB ... Read More

August 19, 2022 / PMPRB, What's New

On August 18, 2022, PMPRB announced its decisions regarding Price Regulation of patented medicines during the ‘Interim Period’, ... Read More

July 20, 2022 / PMPRB, What's New

On June 30, 2022, PMPRB issued a Notice and Comment which published its Proposed Interim Guidance and invited ... Read More

June 30, 2022 / News, PMPRB

PMPRB Launches Consultation on its Proposed Interim Guidance Today, June 30, 2022, PMPRB published a ... Read More

June 28, 2022 / News, What's New

François-Xavier has joined PDCI Market Access as a Senior Health Economist. He is responsible for ... Read More

On May 3, 2022, CADTH announced the mandate expansion of the Scientific Advice Program to include advice on ... Read More

April 25, 2022 / PMPRB, What's New

On April 14, 2022, Health Canada announced that the government will: Proceed only with the proposed amendments to ... Read More

April 11, 2022 / CADTH, News

The Canadian Agency for Drugs and Technologies in Health (CADTH) has published Issue 28 of its Pharmaceutical Reviews ... Read More